Vanguard's Disclosure on Spire Healthcare Stake

On February 6, 2026, The Vanguard Group, Inc. disclosed its investment position in Spire Healthcare Group plc. This announcement follows the requirements outlined in Rule 8.3 of the Takeover Code. The disclosure reveals that Vanguard holds a 3.58% stake in Spire, amounting to 14,431,765 ordinary shares.

The filing indicates that as of February 5, 2026, Vanguard had no cash-settled or stock-settled derivative positions. Additionally, no new securities' subscription rights were declared in the current disclosure. Vanguard's recent activity included purchasing 2,502 ordinary shares at a price of 2.02 GBP each.

No indemnity or other dealing arrangements were reported, nor were there any agreements or understandings related to options or derivatives. The form does not include any Supplemental Form 8, suggesting no open positions. The disclosure was finalized by Shawn Acker, emphasizing transparency in Vanguard's dealings.